Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

COVID-19 pandemic demands a swift response to find therapeutic tools that effectively reduce morbidity and mortality. Despite initial fears, evidence from retrospective observational studies supports the inhibition of the renin-angiotensin system as an emerging pathway to delay or moderate angiotens...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Rothlin, Rodolfo Pedro, Duarte, Mariano, Pelorosso, Facundo Germán, Nicolosi, Liliana, Salgado, M. Victoria, Vetulli, Héctor Miguel, Spitzer, Eduardo
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039444/
https://ncbi.nlm.nih.gov/pubmed/33854432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.603736
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados